All Type of News
Janssen Korea names two female executivesJanssen Korea said Monday that it appointed two females, Min Hyang-won and Lim Kyung-hwa, to executive posts.
Newly appointed director Min will lead the company’s regulatory ...
|
KPMA picks new communication directorThe Korea Pharmaceutical Manufacturers Association (KPMA) yesterday picked an ex-journalist Lee Jae-gook to work as its new communication director.
Lee was appointed to make ...
|
NHIC, healthcare organizations agree on next year’s medical and dispensing fees
The National Health Insurance Corporation Friday finalized its mid-night negotiations with the count’s four medical and pharmaceutical organizations with full agreement on medical and drug dispensing fees in 2014 for ...
Two thirds of Korean drugmakers struggle to cut promotion expenses in first quarter
Influenced by the government-mandated cuts in drug prices last year, Korean drug manufacturers are finding ways to stem predicted losses by slashing their promotion expenditures, according to data obtained by Yakup.co...
Korean drugmakers rebound domestically
Korean drugmakers are bouncing back fast in the domestic market on the back of recovering profit margin thanks to their active marketing activities and less spending on promotion, figures showed Monday.
According t...
Generic Glivec market heating up
Various generic forms of Glivec will flood the domestic market as Swiss pharmaceutical company Novartis’s patent rights to use a chemical substance essential to treat chronic myeloid leukemia expired on June 3.
Acc...
Coesia opens Korean branch
Coesia, a group of industrial solutions companies operating globally, headquartered in Bologna, Italy, said last Friday that it has opened a branch at Kangnam in Seoul as part of efforts to expand its overseas busines...
Korean drug makers rebound in first quarter
The nation’s 42 listed pharmaceutical firms may have bottomed out in earnings in the first quarter as their operating profits have shown signs of improvement on the back of decreased promotion expenses, figures showed...
Health Insurance to cover three new medications from next month
The Ministry of Health and Welfare said Wednesday that national health Insurance will cover Hanmi Pharm’s Pahtension (sildenafil citrate), Otsuka Pharm’s Samsca (tolvaptan) and Takeda Pharm’s Daxas (roflumilast) from ...
116 drug patents listed in Korea’s green list in May
The Ministry of Food and Drug Safety (MFDS) said Thursday that 116 medicinal products (most of foreign drugs except Handok Pharm’s Soliris and Aggrastat and Hyundai Pharm’s Zindaclin) were newly included into green li...
